BREKIYA 1 mg/mL
Dihydroergotamine Mesylate · INJECTION · Amneal Pharmaceuticals LLC
BREKIYA is a injection containing dihydroergotamine mesylate at 1 mg/mL, taken subcutaneous. Manufactured by Amneal Pharmaceuticals LLC.
Key Facts
- Brand Name
- BREKIYA
- Generic Name
- Dihydroergotamine Mesylate
- NDC Code (Product)
64896-509- Manufacturer
- Amneal Pharmaceuticals LLC
- Strength
- 1 mg/mL
- Dosage Form
- INJECTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- NDA215400
- Marketing Start
- 05/16/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is BREKIYA used for?
BREKIYA contains Dihydroergotamine Mesylate. It is a injection taken subcutaneous. Consult your doctor for specific uses.
Is BREKIYA a controlled substance?
BREKIYA is not classified as a controlled substance by the DEA.
What is the generic name for BREKIYA?
The generic name for BREKIYA is Dihydroergotamine Mesylate. There are 11 other brand versions of Dihydroergotamine Mesylate.
What is the NDC code for BREKIYA 1 mg/mL?
The NDC (National Drug Code) for BREKIYA 1 mg/mL is 64896-509, listed by Amneal Pharmaceuticals LLC.
Other Dihydroergotamine Brands
See all →- ATZUMI5.2 mg/176978-101
- Dihydroergotamine Mesylate1 mg/mL81284-411
- Dihydroergotamine Mesylate1 mg/mL0143-9273
- Trudhesa4 mg/mL77530-725
- Dihydroergotamine Mesylate4 mg/mL68682-357
- Dihydroergotamine Mesylate Nasal4 mg/mL69097-503
- dihydroergotamine mesylate1 mg/mL36000-300
- Dihydroergotamine Mesylate1 mg/mL68083-466
- Dihydroergotamine Mesylate1 mg/mL0143-9151
- Dihydroergotamine mesylate4 mg/mL72888-096
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)